Rainmed Medical Limited
SEHK:2297 株式レポート
Rainmed Medical マネジメント Rainmed Medicalの CEO はYunfei Huoで、 Dec2021年に任命され、 の在任期間は 2.92年です。 の年間総報酬はCN¥ 3.35Mで、 54.2%給与と45.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の32.22%を直接所有しており、その価値はHK$ 62.46M 。経営陣と取締役会の平均在任期間はそれぞれ2.9年と2.9年です。
主要情報 CEO給与比率 54.2% CEO在任期間 2.9yrs CEOの所有権 32.2% 経営陣の平均在職期間 2.9yrs 取締役会の平均在任期間 2.9yrs
経営陣の近況
CEO & Executive Chairman of the Board recently bought HK$67k worth of stock Sep 05 Rainmed Medical Limited Announces Resignation of Zhang Liang as Chief Financial Officer
Rainmed Medical Limited, Annual General Meeting, Jun 28, 2024 Mar 30
Rainmed Medical Limited, Annual General Meeting, Jun 28, 2024 Mar 29
CEO & Executive Chairman of the Board recently bought HK$122k worth of stock Dec 30
Chairman of the Board & CEO recently bought HK$78k worth of stock Oct 24
すべての更新を表示
First half 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.041 loss in 1H 2023) Oct 02
CEO & Executive Chairman of the Board recently bought HK$67k worth of stock Sep 05 Rainmed Medical Limited Announces Resignation of Zhang Liang as Chief Financial Officer
Rainmed Medical Limited to Report First Half, 2024 Results on Aug 30, 2024 Aug 15
Rainmed Medical Limited, Annual General Meeting, Jun 28, 2024 Mar 30
Rainmed Medical Limited, Annual General Meeting, Jun 28, 2024 Mar 29
Rainmed Medical Limited to Report Fiscal Year 2023 Results on Mar 28, 2024 Mar 09
CEO & Executive Chairman of the Board recently bought HK$122k worth of stock Dec 30
Chairman of the Board & CEO recently bought HK$78k worth of stock Oct 24
First half 2023 earnings released: CN¥0.041 loss per share (vs CN¥1.88 loss in 1H 2022) Sep 28
New major risk - Revenue and earnings growth Aug 31
Rainmed Medical Limited to Report First Half, 2023 Results on Aug 30, 2023 Aug 10
New minor risk - Share price stability Jul 21
New minor risk - Market cap size Jul 11
Less than half of directors are independent Nov 16
Rainmed Medical Limited to Report First Half, 2022 Results on Aug 30, 2022 Aug 13
Rainmed Medical Limited has completed an IPO in the amount of HKD 145.69152 million. Jul 08
Less than half of directors are independent Jul 08
CEO報酬分析 Rainmed Medical の収益と比較して、Yunfei Huo の報酬はどのように変化したか？ 日付 総報酬 給与 会社業績 Jun 30 2024 n/a n/a -CN¥110m
Mar 31 2024 n/a n/a -CN¥113m
Dec 31 2023 CN¥3m CN¥2m -CN¥116m
Sep 30 2023 n/a n/a -CN¥150m
Jun 30 2023 n/a n/a -CN¥183m
Mar 31 2023 n/a n/a -CN¥765m
Dec 31 2022 CN¥9m CN¥2m -CN¥1b
Sep 30 2022 n/a n/a -CN¥1b
Jun 30 2022 n/a n/a -CN¥2b
Mar 31 2022 n/a n/a -CN¥1b
Dec 31 2021 CN¥36m CN¥1m -CN¥634m
報酬と市場: Yunfeiの 総報酬 ($USD 462.50K ) は、 Hong Kong市場 ($USD 233.84K ) の同規模の企業の平均を上回っています。
報酬と収益: Yunfeiの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者 Mr. Yunfei Huo is Executive Chairman of the Board & Chief Executive Officer of Rainmed Medical Ltd from December 10, 2021. He joined the Rainmed Medical Ltd on August 07, 2014. Mr. Huo founded Suzhou Runxi ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 CEO & Executive Chairman of the Board 2.9yrs CN¥3.35m 32.22% HK$ 62.5m Joint CEO & Executive Director 2.9yrs CN¥2.93m 2.65% HK$ 5.1m Chief Technology Officer 2.9yrs データなし データなし Sales Director no data データなし データなし International Marketing Manager no data データなし データなし VP & Executive Director 2.9yrs CN¥1.87m 0.46% HK$ 890.4k Joint Company Secretary 2.9yrs CN¥3.07m 0.38% HK$ 733.7k VP & Board Secretary no data データなし データなし Vice President 2.9yrs データなし データなし Vice President 2.9yrs データなし データなし Joint Company Secretary 2.9yrs データなし データなし
もっと見る
経験豊富な経営陣: 2297の経営陣は 経験豊富 であると考えられます ( 2.9年の平均在職年数)。
取締役 名称 ポジション 在職期間 報酬 所有権 CEO & Executive Chairman of the Board 3.6yrs CN¥3.35m 32.22% HK$ 62.5m Joint CEO & Executive Director 2.9yrs CN¥2.93m 2.65% HK$ 5.1m VP & Executive Director 3yrs CN¥1.87m 0.46% HK$ 890.4k Independent Non-Executive Director 2.9yrs CN¥252.00k データなし Independent Non-Executive Director 2.9yrs CN¥252.00k データなし Non-Executive Director 3yrs データなし データなし Non-Executive Director 3yrs データなし データなし Independent Non-Executive Director 1.3yrs CN¥95.00k データなし Non-Executive Director less than a year データなし 0.036% HK$ 69.7k
もっと見る
経験豊富なボード: 2297の 取締役会 は 経験豊富 ではない ( 2.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}